Researchers collected survey data from over 500 people with bipolar disorder about their experiences using psilocybin, the results of which were published in a previous paper.
Read moreBelief Changes with Psychedelics
In a recent study, published on Nov. 1 in the Journal of Psychopharmacology, experts from the Johns Hopkins Center for Psychedelic and Consciousness Research explored belief changes related to psychedelic experiences.
They found that a single psychedelic experience increased a range of nonphysicalist beliefs as well as beliefs about consciousness, meaning and purpose.
Read morePsychedelics and the Brain-New Research
Psychedelic drugs may reopen critical learning periods in the brain.
Recent research shows that in adult mice, psychedelic drugs including LSD, ketamine and psilocybin have been shown to reopen the brain to a critical window for social learning usually only seen in adolescents.
Read morePsilocybin and Antidepressants
New research suggests that antidepressants can diminish the effects of psilocybin.
Read moreRecent Research on Psilocybin Gives Mixed Results
Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.
Read moreMDMA and Eating Disorders
MDMA-assisted psychotherapy shows promise in the treatment of eating disorder symptoms.
Read moreMDMA and Chronic Pain
MDMA and Trauma
Reports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.
Read morePsychedelics and Mental Health: Recent Research
Psychedelic drugs can induce mind-altering states affecting perception, thought and sensory input.
They have historically been known for their recreational use and do not have nationwide legal approval.
However, psychedelic drugs are also increasingly being studied for their medical benefits (particularly with regard to mental health).
Learn more below about how certain psychedelics can—and cannot—be used for mental wellness.
Read more5-MeO-DMT- Information, Risks and Research
5-MeO-DMT is less commonly known compared to psilocybin and LSD.
But recently it has been gaining more attention as a therapeutic agent. 5-MeO-DMT creates one of the most powerful psychedelic experiences of any substance known.
Can it be used safely and what are the risks?
Read moreVideo: Psychedelics, Consciousness, and Creativity
Could psychedelics make you more creative? Shift your mind, connect you to others, and help you access a younger, more malleable version of yourself? Activist Rick Doblin, neuroscientist Gül Dölen, and musician Reggie Watts join Brian Greene for a mind-bending and multidisciplinary conversation about the promises and pitfalls of these "magic" molecules and their impact on creativity, connection, and consciousness.
This program is part of the Big Ideas series, supported by the John Templeton Foundation.
Read more